Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04227522
Title Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients (MAMOC)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors North Eastern German Society of Gynaecological Oncology
Indications

fallopian tube cancer

peritoneum cancer

ovarian clear cell carcinoma

endometrioid ovary carcinoma

Therapies

Rucaparib

Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.